MYDA Advisors’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.35M | Buy |
250,000
+70,000
| +39% | +$659K | 0.41% | 46 |
|
|
2025
Q1 | $976K | Buy |
180,000
+20,000
| +13% | +$108K | 0.17% | 61 |
|
|
2024
Q4 | $1.19M | Buy |
160,000
+60,000
| +60% | +$447K | 0.3% | 59 |
|
|
2024
Q3 | $799K | Hold |
100,000
| – | – | 0.18% | 74 |
|
|
2024
Q2 | $870K | Sell |
100,000
-15,000
| -13% | -$131K | 0.19% | 59 |
|
|
2024
Q1 | $2.38M | Buy |
+115,000
| New | +$2.38M | 0.68% | 37 |
|
|
2022
Q4 | – | Sell |
-28,000
| Closed | -$221K | – | 86 |
|
|
2022
Q3 | $221K | Sell |
28,000
-12,000
| -30% | -$94.7K | 0.1% | 101 |
|
|
2022
Q2 | $315K | Sell |
40,000
-15,000
| -27% | -$118K | 0.09% | 119 |
|
|
2022
Q1 | $668K | Buy |
+55,000
| New | +$668K | 0.26% | 99 |
|